title: Serum bupivacaine concentrations and transplacental transfer following repeated epidural administrations in term parturients during labour.
abstract: Bupivacaine is the most widely used local anaesthetic in obstetrics for epidural analgesia. Nineteen women (mean age 26.9 +/- 5.3 years) who underwent epidural analgesia during labour were included in this study. All parturients received a first injection of 21.8 +/- 2.5 mg 0.25% plain bupivacaine. The following administrations were given on request: 0.25% concentration was used when cervix uteri was supple, and a 0.375% concentration when it was tonic. Blood samples were collected 5 min after the first injection and then every 30 min until delivery. At delivery blood samples were collected from the infant umbilical cord vein and from the arm vein of the mother. Bupivacaine was assayed by high pressure liquid chromatography. Serum data were analyzed for each patient using a non-compartmental model. Bupivacaine was rapidly detected in serum, and maximal concentration was reached between 5 and 35 min. Pharmacokinetic parameters were estimated in 17 women after the first injection: 87 +/- 35 min for elimination half-life, 60 +/- 19 L for apparent volume of distribution and 0.5 +/- 0.3 L/min for plasmatic clearance. For a mean total duration of labour and total dose administered of respectively 222 +/- 115 min and 57.1 +/- 28.7 mg the mean value of the foeto-maternal ratio was 0.29 +/- 0.10. The infant maximal serum concentration was 0.26 microgram/mL. No side effects were spontaneously reported by the parturients and all infants had an Apgar score of 10 at 5 min after the delivery. We confirm the fast systemic absorption and rapid elimination of bupivacaine which may be used without risk of acute toxicity both in mother and child, even when it is used in a 0.375% concentration.
authors.affiliation: Service de Pharmacologie Clinique, CHU Hôpital sud, Amiens, France.
authors.forename: G
authors.initials: G
authors.lastname: Decocq
authors.forename: M
authors.initials: M
authors.lastname: Brazier
authors.forename: L
authors.initials: L
authors.lastname: Hary
authors.forename: C
authors.initials: C
authors.lastname: Hubau
authors.forename: M R
authors.initials: MR
authors.lastname: Fortaine
authors.forename: J
authors.initials: J
authors.lastname: Gondry
authors.forename: M
authors.initials: M
authors.lastname: Andréjak
mesh_terms: D000328:Adult; D015360:Analgesia, Epidural; D016362:Analgesia, Obstetrical; D000779:Anesthetics, Local / Q000008:administration & dosage / Q000097:blood* / Q000493:pharmacokinetics; D002045:Bupivacaine / Q000008:administration & dosage / Q000097:blood* / Q000493:pharmacokinetics; D005260:Female; D006801:Humans; D007268:Injections, Epidural; D007751:Labor, Induced; D008431:Maternal-Fetal Exchange; D011247:Pregnancy
chemical_list: D000779:Anesthetics, Local; D002045:Bupivacaine